Ophthalmology – Fuchs’ Heterochromic Iridocyclitis

Basics

Description

Fuchs’ heterochromic iridocyclitis (FHI), also called Fuchs uveitis syndrome, is a chronic, usually unilateral, low-grade anterior uveitis characterized by diffuse iris atrophy, heterochromia, fine stellate keratic precipitates, and minimal external inflammation.

The condition is often relatively asymptomatic. Patients may have only mild blurred vision or floaters, and the eye is typically white and quiet, without the marked pain, photophobia, and redness seen in many other forms of anterior uveitis.

Although traditionally considered unilateral, bilateral disease is recognized and may make heterochromia less obvious.

A strong association exists between FHI and rubella virus, and chronic intraocular immune responses to rubella antigens are thought to play an important etiologic role.

Two major long-term complications are cataract and secondary glaucoma.

Epidemiology

FHI accounts for a relatively small proportion of anterior uveitis cases. It has been estimated to represent less than approximately 6% of anterior uveitis seen in tertiary referral settings.

Its true prevalence may be underestimated because many patients have minimal symptoms and may remain undiagnosed until they develop cataract, glaucoma, or vitreous opacities.

The frequency of FHI has declined in populations with widespread rubella vaccination, particularly among individuals born after introduction of routine childhood immunization programs.

Risk Factors

A history of lack of rubella vaccination or residence in a region without an effective rubella vaccination program may increase risk.

Because the disease may be nearly asymptomatic, patients who do not receive routine eye examinations may not be diagnosed until complications such as advanced glaucoma or visually significant cataract have developed.

No consistent genetic predisposition has been established.

Prevention

The principal preventive strategy is universal rubella vaccination.

Vaccination reduces circulation of rubella virus and appears to reduce the incidence of Fuchs uveitis syndrome in immunized populations.

Pediatric Considerations

FHI is less common among children born after widespread adoption of rubella vaccination.

When the condition is diagnosed in a child or young adult, the patient’s and maternal rubella vaccination history may be relevant.

Pregnancy Considerations

In a pregnant patient with clinical findings compatible with FHI, assessment of rubella immunity is important because primary rubella infection during pregnancy, especially early gestation, can cause congenital rubella syndrome.

The presence of FHI itself does not mean that the patient has an acute systemic rubella infection.

Pathophysiology

Fuchs uveitis syndrome is thought to result from a chronic, localized intraocular immune response, frequently associated with persistent exposure to rubella viral antigens.

A predominantly CD8-positive T-cell-mediated immune response has been demonstrated within the eye.

This chronic low-grade inflammation results in progressive iris stromal atrophy, characteristic keratic precipitates, abnormalities of the anterior chamber angle vessels, and eventually complications such as cataract and glaucoma.

Unlike many other forms of anterior uveitis, the inflammatory response is usually mild and does not typically produce posterior synechiae.

Etiology

Evidence strongly supports an association with rubella virus.

Intraocular production of rubella-specific antibodies has been detected in a high proportion of patients with the classic clinical syndrome.

Rubella viral RNA has also been detected in some ocular samples, especially in younger patients.

The disease is therefore thought to represent a chronic ocular immune response related to prior rubella infection rather than active systemic rubella disease.

Commonly Associated Conditions

The two most important associated ocular complications are cataract and glaucoma.

Cataract develops in a substantial proportion of affected eyes, often becoming the major cause of reduced vision.

Secondary glaucoma occurs less frequently but may be difficult to control and can cause permanent optic nerve damage.

Vitreous opacities are also common and can produce symptomatic floaters or reduced visual quality.

Diagnosis

History

Patients are commonly young or middle-aged and may be asymptomatic.

When symptoms occur, they may include mild unilateral blurred vision, gradual change in iris color, floaters, or mild ocular discomfort.

Severe pain, marked photophobia, and prominent redness are unusual and should raise suspicion for another diagnosis.

Some patients first present because of progressive visual loss from cataract or glaucoma.

Physical Examination

External Appearance

The affected eye usually appears white and quiet, despite the presence of chronic intraocular inflammation.

This absence of prominent conjunctival injection is an important diagnostic clue.

Heterochromia

Iris heterochromia is common.

In patients with dark irides, the affected eye typically appears lighter because of progressive iris stromal atrophy.

In patients with light-colored irides, the affected eye may paradoxically appear darker because thinning of the anterior iris stroma allows greater visualization of the underlying pigment epithelium.

In bilateral disease, obvious heterochromia may be absent.

Keratic Precipitates

A characteristic finding is the presence of diffuse, fine, stellate, nongranulomatous keratic precipitates distributed widely over the corneal endothelium.

Unlike the inferiorly concentrated keratic precipitates seen in many other forms of anterior uveitis, those in FHI are often diffusely distributed.

Anterior Chamber

A mild chronic anterior chamber cellular reaction may be present.

Inflammation is usually low grade.

Posterior synechiae are typically absent, which is a useful distinguishing feature from many other chronic anterior uveitides.

Peripheral anterior synechiae are also not characteristic.

Iris Atrophy

Diffuse iris stromal atrophy is typical and contributes to heterochromia.

The iris architecture may become less distinct over time.

Anterior Chamber Angle

Gonioscopy may demonstrate abnormal fine vessels crossing or bridging the anterior chamber angle.

These fragile vessels are clinically important because they may bleed during surgery or other intraocular manipulation.

Cataract

Cataract is a very common long-term complication and may become the principal cause of visual impairment.

Glaucoma

Secondary glaucoma may develop and requires careful long-term monitoring because FHI is often asymptomatic.

Vitreous

Vitreous cells and opacities are common and may cause floaters or reduced visual quality.

Posterior segment disease is otherwise uncommon, although occasional chorioretinal scars or cystoid macular edema may occur.

Diagnostic Tests and Interpretation

Clinical Diagnosis

In many patients, the diagnosis can be made from the characteristic clinical pattern of:

quiet eye + diffuse stellate keratic precipitates + iris atrophy or heterochromia + absence of posterior synechiae + vitreous involvement.

Not every finding is present simultaneously, so repeated examinations may be helpful.

Intraocular Rubella Antibody Testing

When the diagnosis is uncertain, analysis of aqueous humor for intraocular rubella antibody production can provide strong laboratory support.

A modified Goldmann–Witmer coefficient or antibody index may be used to compare intraocular and serum rubella-specific antibody levels.

Detection of significant intraocular rubella antibody production strongly supports FHI, while absence of such antibody makes the diagnosis less likely in a clinically ambiguous case.

This testing is generally reserved for selected patients rather than routinely performed in every classic case.

Oligoclonal IgG

Intraocular oligoclonal IgG has been reported in FHI, but it is not specific enough to replace clinical diagnosis or pathogen-directed antibody testing.

Photography

External and slit-lamp photography may be useful to document heterochromia, iris atrophy, cataract progression, and other structural changes.

Pathological Findings

Histopathologic specimens demonstrate lymphocytes and plasma cells, supporting the concept of a chronic immune-mediated response.

These findings are consistent with persistent viral antigen-driven intraocular inflammation.

Differential Diagnosis

The differential diagnosis includes other causes of chronic unilateral anterior uveitis, especially herpes simplex virus, varicella-zoster virus, toxoplasmosis-associated uveitis, and Posner–Schlossman syndrome.

Herpetic anterior uveitis may produce elevated intraocular pressure and iris atrophy but is more likely to show sectoral rather than diffuse iris atrophy and may be associated with corneal disease.

Posner–Schlossman syndrome is characterized by recurrent episodes of markedly elevated intraocular pressure with relatively mild inflammation, but it does not typically produce the full classic picture of diffuse iris atrophy and stellate keratic precipitates.

Other causes of heterochromia include Horner syndrome and iris melanoma.

The absence of posterior synechiae despite chronic inflammation is particularly supportive of FHI.

Treatment

Inflammation

Unlike most forms of anterior uveitis, chronic low-grade inflammation in FHI often does not require topical corticosteroid therapy.

Steroid drops may have limited effect on the underlying inflammation and can increase the risk of cataract formation and steroid-induced ocular hypertension or glaucoma.

Therefore, mild asymptomatic inflammation is often observed rather than chronically treated.

If significant inflammation occurs around ocular surgery or in an atypical exacerbation, short-term corticosteroid treatment may be appropriate.

Glaucoma

Secondary glaucoma should be treated aggressively because glaucomatous optic neuropathy is an important cause of permanent visual loss.

Initial treatment usually involves standard intraocular pressure-lowering medications.

Patients with poorly controlled pressure or progressive optic nerve or visual-field damage should be referred to a glaucoma specialist.

Surgical glaucoma treatment may ultimately be necessary.

Cataract Surgery

Cataract extraction can provide substantial visual improvement when the cataract is the major cause of reduced vision.

However, surgery may be complicated by bleeding from the fragile abnormal angle vessels.

A characteristic finding is Amsler sign, in which blood appears in the anterior chamber following paracentesis or intraocular manipulation because of rupture of these abnormal vessels.

Perioperative topical corticosteroids, and occasionally systemic anti-inflammatory therapy, may be used to limit surgery-induced inflammation.

Postoperative visual outcome may still be limited by glaucoma, vitreous opacities, posterior capsule opacification, or other ocular pathology.

Vitrectomy

Pars plana vitrectomy may be considered when dense or persistent vitreous opacities cause significant visual impairment.

This is generally reserved for patients whose symptoms cannot be explained by cataract or other anterior segment abnormalities.

Referral

Patients with uncontrolled intraocular pressure, progressive optic nerve damage, or worsening visual-field loss should be referred to a glaucoma specialist.

Referral to a uveitis specialist may be useful when the diagnosis is uncertain or when the clinical presentation is atypical.

Follow-Up

Because FHI is a chronic and frequently asymptomatic disease, regular ophthalmic follow-up is essential even when the patient feels well.

The interval depends largely on the presence and severity of glaucoma and cataract.

Follow-up should include assessment of visual acuity, intraocular pressure, optic nerve status, cataract progression, anterior chamber inflammation, and vitreous opacities.

Patients with glaucoma require appropriate optic nerve imaging and visual-field monitoring.

Patient Education

Patients should understand that the disease is usually chronic but often causes little discomfort.

They should be informed that lack of pain or redness does not mean the disease is inactive or harmless, because glaucoma can progress without symptoms.

Compliance with prescribed glaucoma therapy and scheduled follow-up is particularly important.

Patients should also understand that cataract is common but is generally treatable surgically.

Prognosis

The visual prognosis is generally good when glaucoma and cataract are recognized and treated appropriately.

Many patients maintain useful vision for many years.

The most important threat to irreversible vision loss is uncontrolled secondary glaucoma, whereas cataract-related vision loss is usually reversible with surgery.

Vitreous opacities and occasional posterior segment complications can also limit final vision.

Complications

Major complications include cataract, secondary glaucoma, vitreous opacities, and occasional cystoid macular edema.

Cataract or glaucoma surgery may be complicated by intraoperative or postoperative hyphema because of abnormal angle vessels.

Permanent visual loss is most likely when glaucoma is diagnosed late or remains inadequately controlled.